Related Experiment Video

Updated: Jan 9, 2026

Ultrasonic Assessment of Myocardial Microstructure
10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

5.8K

Geometry over thickness: Refining echocardiographic recognition of amyloid cardiomyopathy

Bruno Bezerra Lima1, Aamuktha R Karla2, Ahmad Masri3

  • 1Department of Medicine, Cardiology Division, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Radiology, Cardiothoracic Imaging Section, Vanderbilt University Medical Center, Nashville, TN, USA.

Progress in Cardiovascular Diseases
|December 4, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AL amyloidosisCardiac amyloidosisDiagnostic imagingEchocardiographyHeart failure with preserved ejection fractionLeft ventricular hypertrophyLeft ventricular wall thicknessRelative wall thicknessTransthyretin amyloidosis

More Related Videos

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
10:22

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse

Published on: October 26, 2017

22.5K
Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

2.9K

Related Experiment Videos

Last Updated: Jan 9, 2026

Ultrasonic Assessment of Myocardial Microstructure
10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

5.8K
Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
10:22

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse

Published on: October 26, 2017

22.5K
Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

2.9K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374

Articles linked to this work by shared authors, journal, and citation graph.

Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial.

Journal of the American Heart Association·2026

124Iodine Evuzamitide Positron Emission Tomography in Patients with Established or Suspected Cardiac Amyloidosis.

JACC. Cardiovascular imaging·2026

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

JAMA·2026

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

JAMA·2026

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Circulation·2026

Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.

JACC. Heart failure·2026

Artificial intelligence for risk prediction in atherosclerotic cardiovascular disease: A narrative review of advances, validation challenges, and clinical translation (2020-2026).

Progress in cardiovascular diseases·2026

Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.

Progress in cardiovascular diseases·2026

Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank.

Progress in cardiovascular diseases·2026

Obesity, lipids, inflammation, and healthy aging.

Progress in cardiovascular diseases·2026

Conduction system pacing as a primary strategy for cardiac resynchronization therapy in reduced ejection fraction: An updated systematic review and meta-analysis of randomized controlled trials.

Progress in cardiovascular diseases·2026

Revascularization options for managing patients with multi-vessel coronary artery disease.

Progress in cardiovascular diseases·2026

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

JACC. Heart failure·2026

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

European journal of preventive cardiology·2026

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Polish archives of internal medicine·2026

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us